DIVI S LABORATORIES LTD vs Fredun Pharmaceuticals Ltd

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and Fredun Pharmaceuticals Ltd (FREDUNPHARMACEUTICALSLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs FREDUNPHARMACEUTICALSLTD on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
44.50
10.72
P/B ratio
5.40
0.44%
Dividend yield
0.03%
₹96.73
EPS
₹44.07

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
15.80%
22.00%
Return on capital
19.00%
33.00%
EBITDA margin
12.00%
24.32%
Net margin
4.63%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
32.46%
12.10%
Profit CAGR (3Y)
43.64%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹1,460 Cr
₹10,560 Cr
Revenue
₹454 Cr
₹2,568 Cr
Net profit
₹21 Cr
0.00
Debt / equity
0.80
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
Fredun Pharmaceuticals Ltd
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 75.2% CAGR over last 5 years", "Debtor days have improved from 87.9 to 53.2 days.", "Promoter holding has increased by 1.51% over last quarter.", "Company's median sales growth is 28.6% of last 10 years"]
  • ["Promoter holding has decreased over last 3 years: -5.58%"]
DIVI S LABORATORIES LTD full analysis Fredun Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.